For their patients who can’t or won’t stop smoking with medication options… Introducing doctors to the most common reduced-harm alternative […] Read More
14 min. read
14 min. read
For their patients who can’t or won’t stop smoking with medication options… Introducing doctors to the most common reduced-harm alternative […] Read More
4 min. read
It’s no secret that the FDA’s requirements for investigational tobacco product (ITP) applications can be confusing. But what if you […] Read More
6 min. read
By Cheryl K. Olson As part of its new strategic plan, the U.S. Food and Drug Administration’s Center for Tobacco Products […] Read More
6 min. read
by Cheryl K. Olson, M.P.H., Sc.D, originally featured in the Tobacco Reporter On August 22, the U.S. Food and Drug Administration’s […] Read More
2 min. read
McKinney Regulatory Science Advisors (RSA) is proud to announce the launch of its new website, ushering in a new era […] Read More
6 min. read
The primary motivation for the use of medicines is to rectify physiological or psychological perturbations, although the non-therapeutic abuse of […] Read More
3 min. read
McKinney Regulatory Science Advisors, LLC, a leading regulatory science consulting firm specializing in regulatory affairs, is thrilled to announce the […] Read More
8 min. read
What will it take for women who smoke to consider smokeless? by Cheryl K. Olson, M.P.H., Sc.D, originally featured in […] Read More
2 min. read
by Christopher Russell 1, Willie J McKinney, Ian M Fearon This study examines intentions to use a disposable e-cigarette (BIDI […] Read More
"*" indicates required fields